Picture of Valbiotis SA logo

ALVAL — Valbiotis SA News Story

0.000.00%
fr flag iconLast trade - 00:00
HealthcareHighly SpeculativeMicro CapSucker Stock

Brief: -Valbiotis H1 Net Loss Widens to EUR 5.1 Mln

Sept 15 (Reuters) - Valbiotis SA  ALVAL.PA :
    * CONTINUED EXECUTION OF STRATEGIC AND OPERATIONAL ROADMAP
FOR
FUTURE COMMERCIALIZATION (REMOVES REFERENCE TO FY 2021)
    * VALBIOTIS PROVIDES AN UPDATE ON ITS PROGRESS AND PUBLISHES
ITS
FINANCIAL REPORT FOR THE FIRST HALF OF 2022
    * FINANCIAL VISIBILITY UNTIL LAST QUARTER OF 2023, EXCLUDING
POTENTIAL ADDITIONAL REVENUES
    * A CASH POSITION OF EUR 15.4 MILLION AT JUNE 30, 2022.
    * FINANCIAL VISIBILITY UNTIL LAST QUARTER OF 2023, EXCLUDING
POTENTIAL ADDITIONAL REVENUES
    * H1 NET LOSS EUR 5.1 MILLION VERSUS LOSS EUR 3.5 MILLION
YEAR AGO
    * TOTAL OPERATING INCOME FOR FIRST HALF OF YEAR AMOUNTED TO
EUR
1,514,000, COMPARED WITH EUR 748,000 FOR FIRST HALF OF 2021
    * BENEFITS FROM FINANCIAL VISIBILITY UNTIL LAST QUARTER OF
2023,
EXCLUDING POTENTIAL ADDITIONAL REVENUES

Source text: https://bit.ly/3RNsITp
Further company coverage:  ALVAL.PA 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))

Recent news on Valbiotis SA

See all news